info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Endoprosthesis Companies

Endoprostheses are artificial implants used to replace missing or damaged body parts, such as joints or other orthopedic structures. Several companies specialize in the development and manufacturing of endoprosthetic devices.

Endoprosthesis Key CompaniesDisclaimer: List of key companies in no particular orderLatest Endoprostheses Companies Update



  • July 2023: Johnson & Johnson is the most recent pharmaceutical company to file a lawsuit against the US government to thwart a policy that grants the Medicare government-run healthcare plan the authority to bargain for reduced prescription pricing. The pharmaceutical industry claims that President Joe Biden signed the Inflation Reduction Act bill, which will force drugmakers to halt the research of novel therapies and reduce revenues through a medication price negotiating scheme. The Biden administration intends to save $25 billion yearly by 2031 by having Medicare negotiate costs for some of the most expensive medications used by its beneficiaries, who are 65 and older. Americans spend more money than any other nation on prescription drugs.




  • Aug 2023: The rating agency AM Best has given managing general agents (MGAs) Corin Underwriting Limited (UK) and Corin Underwriting (Europe) GmbH (Corin Europe) a performance evaluation of PA-3 (Strong), with a stable outlook. As a result, Corin is the first MGA of its size in the UK to receive such a high-performance rating from Best. Best claims that the evaluation considers several distinct elements, such as Corin's great underwriting skills, superior governance and internal controls, sound financial standing, strong organizational aptitude, and strong depth and breadth of partnerships.


List of Endoprostheses Key companies in the market


  • Johnson & Johnson Services, Inc. (US)




  • Zimmer Biomet Holdings Inc. (US)




  • Stryker (US)




  • Smith & Nephew (UK)




  • Corin Ltd (UK)




  • Medacta International SA (Switzerland)




  • Exactech, inc. (US)




  • MicroPort Orthopedics, Inc. (US)




  • Baumer S.A. (Switzerland)




  • B. Braun Melsungen AG (Germany)



Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.